InMed Pharmaceuticals Inc. - INM
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Sr VP & General Manager | A | A | 8,500.0 | 0.0 | 0.0 | 12,400.0 | View | |
| Dec 19, 2025 | — | A | A | 1,750.0 | 0.0 | 0.0 | 2,725.0 | View | |
| Dec 19, 2025 | — | A | A | 1,750.0 | 0.0 | 0.0 | 5,250.0 | View | |
| Dec 19, 2025 | Chief Financial Officer | A | A | 18,000.0 | 0.0 | 0.0 | 24,250.0 | View | |
| Dec 19, 2025 | Chief Operating Officer | A | A | 18,000.0 | 0.0 | 0.0 | 25,445.0 | View | |
| Dec 19, 2025 | — | A | A | 1,750.0 | 0.0 | 0.0 | 5,250.0 | View | |
| Dec 19, 2025 | Sr. VP, Pre-Clinical Res/Dev | A | A | 13,000.0 | 0.0 | 0.0 | 18,280.0 | View | |
| Dec 19, 2025 | President & CEO | A | A | 35,000.0 | 0.0 | 0.0 | 49,050.0 | View | |
| Dec 19, 2025 | — | A | A | 1,750.0 | 0.0 | 0.0 | 2,711.0 | View | |
| Dec 17, 2025 | — | H | D | 14.0 | 0.0 | 0.0 | 961.0 | View | |
| Dec 17, 2025 | President & CEO | H | D | 250.0 | 0.0 | 0.0 | 14,050.0 | View | |
| Dec 17, 2025 | Chief Operating Officer | H | D | 60.0 | 0.0 | 0.0 | 7,445.0 | View | |
| Dec 17, 2025 | Sr. VP, Pre-Clinical Res/Dev | H | D | 70.0 | 0.0 | 0.0 | 5,280.0 | View |